Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses

  • Lutsiak M
  • Kwon G
  • Samuel J
80Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The type of immune response developed against the hepatitis B virus (HBV) is crucial in determining the outcome of the disease. The protective effects of vaccine-induced antibody responses against subsequent exposure to HBV are well-established. After the establishment of chronic HBV infection, cell-mediated immune response is curative while humoral response is detrimental. A therapeutic vaccine that could switch the type of response could lead to disease resolution. Hepatitis B core antigen (HBcAg)129–140 has been identified as a Th2-biased peptide in H-2b mice when it is administered along with complete Freund's adjuvant (CFA). We formulated HBcAg129–140 along with monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) (PLGA) nanoparticles. Naïve mice immunized with the nanoparticle formulation developed a strong Th1-type response while mice immunized with the control formulation of CFA and peptide did not. We then primed mice with CFA and peptide to establish a Th2-type immune response before administering the nanoparticle formulation. Mice receiving the nanoparticle formulation being primed with CFA still developed a strong Th1-type response, while mice that received incomplete Freund's adjuvant and peptide instead of nanoparticles did not. The ability of PLGA nanoparticles to alter the type of immune response elicited by a peptide, even in the context of an ongoing immune response, makes PLGA nanoparticles a strong candidate for the formulation of therapeutic vaccines.

References Powered by Scopus

TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties

7242Citations
N/AReaders
Get full text

Toll-like receptors

4937Citations
N/AReaders
Get full text

Two types of mouse t helper cell: IV. Th2 clones secrete a factor that inhibits cytokine production by Thl clones

2676Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Immunological properties of engineered nanomaterials

1569Citations
N/AReaders
Get full text

Nanoparticle vaccines

804Citations
N/AReaders
Get full text

Nanotechnology in vaccine delivery

518Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lutsiak, M. E. C., Kwon, G. S., & Samuel, J. (2010). Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses. Journal of Pharmacy and Pharmacology, 58(6), 739–747. https://doi.org/10.1211/jpp.58.6.0004

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 28

68%

Researcher 7

17%

Professor / Associate Prof. 3

7%

Lecturer / Post doc 3

7%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 14

50%

Medicine and Dentistry 6

21%

Pharmacology, Toxicology and Pharmaceut... 4

14%

Chemistry 4

14%

Save time finding and organizing research with Mendeley

Sign up for free